Table 4

Neurological adverse events of interest

EventsTotal, n/N (%)0–24 hours, n/N (%)>24 hours–30 days, n/N (%)31 days–1 year, n/N (%)1–3 years, n/N (%)
Stroke
 Major2/63 (3.2%)0/63 (0.0%)1/63 (1.6%)1/62 (1.6%)0/56 (0.0%)
 Minor1/63 (1.6%)0/63 (0.0%)0/63 (0.0%)1/62 (1.6%)0/56 (0.0%)
 TIA3/63 (4.8%)0/63 (0.0%)2/63 (3.2%)0/62 (0.0%)1/56 (1.8%)
Intracranial hemorrhage2/63 (3.2%)*1/63 (1.6%)*0/63 (0.0%)1/62 (1.6%)0/56 (0.0%)
 SAH2/63 (3.2%)1/63 (1.6%)0/63 (0.0%)1/62 (1.6%)0/56 (0.0%)
 IPH0/63 (0.0%)0/63 (0.0%)0/63 (0.0%)0/62 (0.0%)0/56 (0.0%)
 EDH0/63 (0.0%)0/63 (0.0%)0/63 (0.0%)0/62 (0.0%)0/56 (0.0%)
 SDH0/63 (0.0%)0/63 (0.0%)0/63 (0.0%)0/62 (0.0%)0/56 (0.0%)
 IVH1/63 (1.6%)1/63 (1.6%)0/63 (0.0%)0/62 (0.0%)0/56 (0.0%)
  • *In these cases, one patient had two intracranial haemorrhage events in the given period and was counted only once.

  • EDH, epidural haemorrhage; IPH, intraparenchymal haemorrhage; IVH, intraventricular haemorrhage; SAH, subarachnoid haemorrhage; SDH, subdural haemorrhage; TIA, transient ischemic attack.